0001193125-21-010735.txt : 20210119 0001193125-21-010735.hdr.sgml : 20210119 20210119062153 ACCESSION NUMBER: 0001193125-21-010735 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20210119 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210119 DATE AS OF CHANGE: 20210119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC. CENTRAL INDEX KEY: 0001750019 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474152751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38811 FILM NUMBER: 21533788 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-5200 MAIL ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 8-K 1 d27901d8k.htm 8-K 8-K
false 0001750019 0001750019 2021-01-19 2021-01-19

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Act of 1934

Date of Report (Date of earliest event reported):

January 19, 2021

 

 

TCR2 THERAPEUTICS INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38811   47-4152751
(State or other jurisdiction of
incorporation or organization)		   (Commission
File Number)		   (I.R.S. Employer
Identification Number)

 

100 Binney Street, Suite 710

Cambridge, Massachusetts

   02142
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (617) 949-5200

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common Stock   TCRR   The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 2.02.

Results of Operations and Financial Condition.

On January 19, 2021, TCR2 Therapeutics Inc. (the “Company”) announced that it estimates that its cash and cash equivalents and investments were approximately $228.0 million as of December 31, 2020. These financial results are only preliminary estimates and are based on information available to management as of the date of this Current Report on Form 8-K and these estimates could change. The Company’s actual financial results as of December 31, 2020 are subject to the completion of its financial statements as of and for such period. The Company’s independent registered public accountants have not audited, reviewed or performed any procedures with respect to such preliminary estimates and accordingly, do not express an opinion or any other form of assurance with respect thereto. The Company’s actual results for the year ended December 31, 2020 will be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 and may differ materially from the above estimate.

The information contained in Item 2.02 of this Current Report on Form 8-K is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 8.01

Other Events.

In connection with the proposed registered underwritten public offering, the Company suspended, and during the duration of the proposed public offering is not offering any shares of its common stock pursuant to, the prospectus filed with the Securities and Exchange Commission (the “SEC”) on March 6, 2020 relating to the Open Market Sale AgreementSM, dated March 6, 2020 (the “Sales Agreement”), by and between the Company and Jefferies LLC. The Company will not make any sales of common stock pursuant to the Sales Agreement unless and until a new prospectus supplement is filed with the SEC; however, the Sales Agreement remains in full force and effect.

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, which is being made only by means of a written prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, nor shall there be any sale of the Company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but are not always, made through the use of words or phrases such as “may,” “will,” “could,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “seeks,” “endeavor,” “potential,” “continue,” and similar expressions, or the negative of these terms, or similar expressions. These forward-looking statements include statements about the Company’s anticipated public offering, the preliminary financial results as of December 31, 2020 and the Company’s future expectations, plans and prospects. Accordingly, these statements involve estimates, assumptions, risks and uncertainties which could cause actual results to differ materially from those expressed in them, including the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all. The Company’s forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning the Company’s business are described in additional detail in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and in the Company’s other reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.

   

Description

104    Inline XBRL cover page

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TCR2 THERAPEUTICS INC.
By:  

/s/ Mayur (Ian) Somaiya

Name:   Mayur (Ian) Somaiya
Title:   Chief Financial Officer

Date: January 19, 2021

EX-101.SCH 2 tcrr-20210119.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 tcrr-20210119_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 4 tcrr-20210119_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 d27901d8k_htm.xml IDEA: XBRL DOCUMENT 0001750019 2021-01-19 2021-01-19 false 0001750019 8-K 2021-01-19 TCR2 THERAPEUTICS INC. DE 001-38811 47-4152751 100 Binney Street Suite 710 Cambridge MA 02142 (617) 949-5200 false false false false Common Stock TCRR NASDAQ true false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document and Entity Information
Jan. 19, 2021
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001750019
Document Type 8-K
Document Period End Date Jan. 19, 2021
Entity Registrant Name TCR2 THERAPEUTICS INC.
Entity Incorporation State Country Code DE
Entity File Number 001-38811
Entity Tax Identification Number 47-4152751
Entity Address, Address Line One 100 Binney Street
Entity Address, Address Line Two Suite 710
Entity Address, City or Town Cambridge
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02142
City Area Code (617)
Local Phone Number 949-5200
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock
Trading Symbol TCRR
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d27901d8k.htm tcrr-20210119.xsd tcrr-20210119_lab.xml tcrr-20210119_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d27901d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d27901d8k.htm" ] }, "labelLink": { "local": [ "tcrr-20210119_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "tcrr-20210119_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "tcrr-20210119.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "tcrr", "nsuri": "http://www.tcr2.com/20210119", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d27901d8k.htm", "contextRef": "duration_2021-01-19_to_2021-01-19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d27901d8k.htm", "contextRef": "duration_2021-01-19_to_2021-01-19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tcr2.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 13 0001193125-21-010735-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-010735-xbrl.zip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